BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36800556)

  • 1. Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
    Roznovjak D; Petroll AE; Lakatos AEB; Narayan R; Cortina CS
    JCO Oncol Pract; 2023 May; 19(5):e794-e800. PubMed ID: 36800556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
    Green AE; DeChants JP; Price MN; Davis CK
    J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-Affirming Hormone Therapy and Cervical Cancer Screening Rates in Transgender Men and Nonbinary People: A Cross-Sectional Study from a Boston Community Health Center.
    Fleming J; Grasso C; Mayer KH; Reisner SL; Potter J; Streed CG
    LGBT Health; 2024 Apr; ():. PubMed ID: 38669119
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast Cancer Among Transgender and Nonbinary Patients: Paradigms for Improving Data Collection and Inclusion in Breast Imaging Settings.
    Ly D; Hoyt AC; Weimer A; Chang EH; Capiro N; Xie C; Chow L
    J Breast Imaging; 2023 Feb; 5(1):73-79. PubMed ID: 38416956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.
    Iwamoto SJ; Grimstad F; Irwig MS; Rothman MS
    J Gen Intern Med; 2021 May; 36(5):1380-1389. PubMed ID: 33547576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.
    Berner AM; Connolly DJ; Pinnell I; Wolton A; MacNaughton A; Challen C; Nambiar K; Bayliss J; Barrett J; Richards C
    Br J Gen Pract; 2021 Aug; 71(709):e614-e625. PubMed ID: 34001539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals.
    Cathcart-Rake EJ; Ruddy KJ; Tevaarwerk AJ; Jatoi A
    Maturitas; 2024 Mar; 181():107913. PubMed ID: 38262089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.
    Gupta P; Patterson BC; Chu L; Gold S; Amos S; Yeung H; Goodman M; Tangpricha V
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1236-e1244. PubMed ID: 37246711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single-Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
    Luehmann N; Ascha M; Chwa E; Hackenberger P; Termanini K; Benning C; Sama D; Felt D; Beach LB; Gupta D; Kulkarni SA; Jordan SW
    Ann Surg Oncol; 2022 Mar; 29(3):1707-1717. PubMed ID: 34704183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer in transgender women: what does a urologist need to know?
    Bertoncelli Tanaka M; Sahota K; Burn J; Falconer A; Winkler M; Ahmed HU; Rashid TG;
    BJU Int; 2022 Jan; 129(1):113-122. PubMed ID: 34157213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
    Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
    Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
    Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
    BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
    Berzansky I; Reynolds CA; Charlton BM
    Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Anogenital Gonorrhea and Chlamydia in Transgender and Gender Diverse Primary Care Patients Receiving Gender-Affirming Hormone Therapy.
    Reisner SL; Deutsch MB; Mayer KH; Pletta DR; Campbell J; Potter J; Keuroghlian AS; Hughto JMW; Asquith A; Pardee DJ; Harris A; Quint M; Grasso C; Gonzalez A; Radix A
    J Gen Intern Med; 2024 May; 39(7):1164-1172. PubMed ID: 37989820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and reproductive cancers in the transgender population: a systematic review.
    Joint R; Chen ZE; Cameron S
    BJOG; 2018 Nov; 125(12):1505-1512. PubMed ID: 29706033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
    Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
    J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.